Meet the 2017 Foreign Company of the Year Finalists

AmCham Denmark is pleased to announce the three finalists for the 2017 Foreign Company of the Year. We congratulate these outstanding companies and wish them well as AmCham's independent jury evaluates their accomplishments. The winner will be announced at AmCham's Fall Member Dinner at Sølyst on October 25, 2017. To register for the event, click here.

Bristol-Myers Squibb
Bristol-Myers Squibb Company (BMS) is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Our medicines help millions of people globally in their fight against diseases in the areas of oncology, Immuno-Oncology, immunoscience, cardiovascular diseases, fibrotic diseases and genetically defined diseases – all of which are areas of high unmet medical needs. At Bristol-Myers Squibb, our biopharmaceutical strategy uniquely combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a successful biotech company.

Medtronic is a global leader in medical technology, redefining how technology is used in the management of chronic diseases. The company's deep understanding of human physiology yields unique insight into a range of therapeutic areas including heart and vascular diseases, diabetes, neurological disorders and spinal conditions. Medtronic’s years of experience, broad range of offerings, and partnership with both medical professionals and the overall Healthcare system, make it possible for millions of people to resume everyday activities, return to work, and live better and longer.

Phillip Morris
Philip Morris International has made a dramatic decision, and embarked on a future squarely focused on replacing cigarettes with smoke-free products, offering the millions of men and women who chose to continue to smoke a better alternative. Our vision is that these products will one day replace cigarettes. Society expects us to act responsibly. Philip Morris is doing just that by designing a smoke-free future and shifting resources towards this new objective.

In 2017, over 70% of Philip Morris Internationals global R&D expenditures will be allocated to smoke-free products. We have developed breakthrough products that are smoke-free and enjoyable. And, we are selling them today. Over three million people have already given up smoking and switched to our new products, and this is just the beginning. In changing times you can always choose to do nothing. Instead, we’ve set a new course for the company. We’ve chosen to do something really big.

To read more about AmCham's Foreign Company of the Year, click here.

03 Copenhagen Marriott01 Manpower DK04 MSD10 Weibel06 DXC Technology08 Bristol-Myers Squibb05 Crowne Plaza07 Bayer11 Roche02 Lockheed Martin09 Riskpoint
AmCham Denmark · Dag Hammarskjölds Allé 13, 3 · 2100 Copenhagen Ø · Denmark · Phone (+45) 33 932 932 · E-mail: mail@amcham.dk · CVR: 24992314
Copyright© 2010 AmCham Denmark · All Rights Reserved